Gencurix Inc (229000) - Total Assets

Latest as of September 2025: ₩24.88 Billion KRW ≈ $16.86 Million USD

Based on the latest financial reports, Gencurix Inc (229000) holds total assets worth ₩24.88 Billion KRW (≈ $16.86 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 229000 total equity for net asset value and shareholders' equity analysis.

Gencurix Inc - Total Assets Trend (2016–2024)

This chart illustrates how Gencurix Inc's total assets have evolved over time, based on quarterly financial data.

Gencurix Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Gencurix Inc's total assets of ₩24.88 Billion consist of 30.9% current assets and 69.1% non-current assets.

Asset Category	Amount (KRW)	% of Total Assets
Cash & Equivalents	₩754.11 Million	0.0%
Accounts Receivable	₩1.02 Billion	3.4%
Inventory	₩369.77 Million	1.2%
Property, Plant & Equipment	₩13.42 Billion	44.7%
Intangible Assets	₩797.87 Million	2.7%
Goodwill	₩0.00	0.0%

Asset Composition Trend (2016–2024)

This chart illustrates how Gencurix Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Gencurix Inc stock valuation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Gencurix Inc's current assets represent 30.9% of total assets in 2024, a decrease from 80.0% in 2016.
Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, the same as 0.0% in 2016.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 1.0% in 2016.
Asset Diversification: The largest asset category is property, plant & equipment at 44.7% of total assets.

Gencurix Inc Competitors by Total Assets

Key competitors of Gencurix Inc based on total assets are shown below.

Company	Country	Total Assets
Sonic Healthcare Ltd AU:SHL	Australia	AU$17.03 Billion
Eurofins-Cerep SA PA:ALECR	France	€84.58 Million
Inoviq Ltd AU:IIQ	Australia	AU$24.52 Million
Bcal Diagnostics Ltd AU:BDX	Australia	AU$7.17 Million
Imagion Biosystems Ltd AU:IBX	Australia	AU$932.48K
Integral Diagnostics Ltd AU:IDX	Australia	AU$1.43 Billion
Australian Clinical Labs Ltd AU:ACL	Australia	AU$562.50 Million
Monash Ivf Group Ltd AU:MVF	Australia	AU$510.21 Million

Gencurix Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.39	0.56	1.30
Quick Ratio	0.35	0.52	0.79
Cash Ratio	0.00	0.02	0.00
Working Capital	₩-9.40 Billion	₩-5.72 Billion	₩2.56 Billion

Gencurix Inc - Advanced Valuation Insights

This section examines the relationship between Gencurix Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6.85
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-10.3%
Total Assets	₩30.04 Billion
Market Capitalization	$25.56 Million USD

Valuation Analysis

Below Book Valuation: The market values Gencurix Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Gencurix Inc's assets decreased by 10.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Gencurix Inc (2016–2024)

The table below shows the annual total assets of Gencurix Inc from 2016 to 2024.

Year	Total Assets	Change
2024-12-31	₩30.04 Billion ≈ $20.36 Million	-10.32%
2023-12-31	₩33.50 Billion ≈ $22.70 Million	-10.03%
2022-12-31	₩37.24 Billion ≈ $25.24 Million	-32.64%
2021-12-31	₩55.29 Billion ≈ $37.47 Million	-13.58%
2020-12-31	₩63.98 Billion ≈ $43.36 Million	+2579.67%
2019-12-31	₩2.39 Billion ≈ $1.62 Million	-76.46%
2018-12-31	₩10.14 Billion ≈ $6.87 Million	+37.79%
2017-12-31	₩7.36 Billion ≈ $4.99 Million	-20.27%
2016-12-31	₩9.23 Billion ≈ $6.26 Million	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$25.56 Million

₩37.72 Billion KRW

Market Cap Rank

#24247 Global

#1766 in Korea

Share Price

₩2340.00

Change (1 day)

-1.68%

52-Week Range

₩1428.00 - ₩5870.00

All Time High

₩23845.65